RxDoctor Payments Data

Gillian Levy, MD

Anatomic Pathology & Clinical Pathology · Norwalk, CTNPI 1467639831

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $749 and has fallen 97.2% since, to $21 in 2025.

$1,128in general payments, 2019–2025

Across 55 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$246
  • Boehringer Ingelheim$218
  • E.r. Squibb & Sons, L.L.C.$143
  • Medline Industries LP$86
  • AstraZeneca$76
  • Lilly USA, LLC$72
  • plus $286 from 10 others

What the payments were for

  • Food & beverage$1,128100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,128 in reported general payments places this provider in the 85th percentile of 94 anatomic pathology & clinical pathology providers in Connecticut.

See all anatomic pathology & clinical pathology providers in Connecticut

Medicare billing

Part B allowed, 2024
$385,545
Medicare patients
1,705
Services billed
4,023

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Norwalk

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →